These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 20217483)
1. Thyroid cancer is the most common cancer associated with acromegaly. Gullu BE; Celik O; Gazioglu N; Kadioglu P Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483 [TBL] [Abstract][Full Text] [Related]
2. Increased thyroid cancer risk in acromegaly. Dagdelen S; Cinar N; Erbas T Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A; J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466 [TBL] [Abstract][Full Text] [Related]
4. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer. Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364 [TBL] [Abstract][Full Text] [Related]
5. Benign and malignant tumors in patients with acromegaly. Barzilay J; Heatley GJ; Cushing GW Arch Intern Med; 1991 Aug; 151(8):1629-32. PubMed ID: 1678593 [TBL] [Abstract][Full Text] [Related]
6. Complications of acromegaly: thyroid and colon. Tirosh A; Shimon I Pituitary; 2017 Feb; 20(1):70-75. PubMed ID: 27631334 [TBL] [Abstract][Full Text] [Related]
7. Acromegaly, growth hormone and cancer risk. Renehan AG; Brennan BM Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124 [TBL] [Abstract][Full Text] [Related]
8. Identification of acromegalic patients at risk of developing colonic adenomas. Bogazzi F; Cosci C; Sardella C; Costa A; Manetti L; Gasperi M; Rossi G; Bartalena L; Martino E J Clin Endocrinol Metab; 2006 Apr; 91(4):1351-6. PubMed ID: 16449330 [TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study. Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901 [TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects. Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of thyroid disease and thyroid malignancy in acromegalic patients. Cankurtaran Y; Örük GG; Tozduman B Minerva Endocrinol (Torino); 2023 Jun; 48(2):130-139. PubMed ID: 33988006 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of differentiated thyroid carcinoma in acromegaly. Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909 [TBL] [Abstract][Full Text] [Related]
13. Increased epithelial cell proliferation in the colon of patients with acromegaly. Cats A; Dullaart RP; Kleibeuker JH; Kuipers F; Sluiter WJ; Hardonk MJ; de Vries EG Cancer Res; 1996 Feb; 56(3):523-6. PubMed ID: 8564965 [TBL] [Abstract][Full Text] [Related]
14. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center. Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013 [TBL] [Abstract][Full Text] [Related]
16. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010 [TBL] [Abstract][Full Text] [Related]
17. High incidence of thyroid cancer among patients with acromegaly. Kaldrymidis D; Papadakis G; Tsakonas G; Kaldrymidis P; Flaskas T; Seretis A; Pantazi E; Kostoglou-Athanassiou I; Peppa M; Roussou P; Diamanti-Kandarakis E J BUON; 2016; 21(4):989-993. PubMed ID: 27685924 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Kurimoto M; Fukuda I; Hizuka N; Takano K Endocr J; 2008 Mar; 55(1):67-71. PubMed ID: 18202526 [TBL] [Abstract][Full Text] [Related]
19. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. Colao A; Marzullo P; Spiezia S; Giaccio A; Ferone D; Cerbone G; Di Sarno A; Lombardi G J Clin Endocrinol Metab; 2000 Oct; 85(10):3754-61. PubMed ID: 11061535 [TBL] [Abstract][Full Text] [Related]
20. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Siegel G; Tomer Y Endocr Res; 2005; 31(1):51-8. PubMed ID: 16238191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]